Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/7/2026

1. HUVR:IN
2. DELL
3. ROIV
4. ANET
5. NKE
6. PANW
7. CL
8. SNDK
9. TAP
10. EAT

Go back to Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update

Catalyst Pharmaceuticals (CPRX) Tops Q3 EPS by 78c, Beats on Revenue; Offers FY23 Revenue Guidance

November 8, 2023 4:29 PM EST

Catalyst Pharmaceuticals (NASDAQ: CPRX) reported Q3 EPS of $0.49, $0.78 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $102.7 million versus the consensus estimate of $100.37 million.

GUIDANCE:

Catalyst Pharmaceuticals sees FY2023 revenue of $390-395 million, versus the consensus of... More